Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T19:16:02.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Several key resources related to rare diseases and clinical trials have been removed, including links to specific disease pages and treatment information, which may impact access to important medical data.
    Difference
    4%
    Check dated 2024-11-23T05:52:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    New resources related to rare diseases and specific treatments, including links to Glioblastoma and Glioma information, as well as drug information for Bevacizumab and Pembrolizumab, have been added.
    Difference
    0.4%
    Check dated 2024-11-16T01:31:47.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    3%
    Check dated 2024-11-08T19:06:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:37:09.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:24:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.